Literature DB >> 15673767

The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump.

Patricia Sanchez1, Eduardo Moreno, Jose L Martinez.   

Abstract

The possibility that triclosan selects Stenotrophomonas maltophilia mutants overexpressing the multidrug resistance pump SmeDEF is analyzed. Five out of 12 triclosan-selected mutants were less susceptible to antibiotics than the wild-type strain and overproduced SmeDEF. Results are discussed in relation to current debates on the potential selection of antibiotic-resistant bacteria by household biocides.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15673767      PMCID： PMC547238          DOI： 10.1128/AAC.49.2.781-782.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia.

Authors:  A Alonso; J L Martinez
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Active efflux, a common mechanism for biocide and antibiotic resistance.

Authors:  S B Levy
Journal:  Symp Ser Soc Appl Microbiol       Date:  2002

Review 3.  Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community.

Authors:  Allison E Aiello; Elaine Larson
Journal:  Lancet Infect Dis       Date:  2003-08       Impact factor: 25.071

4.  Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.

Authors:  R Chuanchuen; K Beinlich; T T Hoang; A Becher; R R Karkhoff-Schweizer; H P Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

5.  SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia.

Authors:  L Zhang; X Z Li; K Poole
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia.

Authors:  A Alonso; J L Martínez
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

7.  Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.

Authors:  E C Cole; R M Addison; J R Rubino; K E Leese; P D Dulaney; M S Newell; J Wilkins; D J Gaber; T Wineinger; D A Criger
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

8.  Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli.

Authors:  L M McMurry; M Oethinger; S B Levy
Journal:  FEMS Microbiol Lett       Date:  1998-09-15       Impact factor: 2.742

9.  The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan.

Authors:  Rungtip Chuanchuen; Craig T Narasaki; Herbert P Schweizer
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

10.  Antibacterial household products: cause for concern.

Authors:  S B Levy
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883
View more
  42 in total

Review 1.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

2.  Efflux pump overexpression in multiple-antibiotic-resistant mutants of Bacteroides fragilis.

Authors:  Lilian Pumbwe; Daniel Glass; Hannah M Wexler
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF.

Authors:  Alvaro Hernández; María J Maté; Patricia C Sánchez-Díaz; Antonio Romero; Fernando Rojo; José L Martínez
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

Review 4.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

5.  Efflux as a glutaraldehyde resistance mechanism in Pseudomonas fluorescens and Pseudomonas aeruginosa biofilms.

Authors:  Amit Vikram; Jennifer M Bomberger; Kyle J Bibby
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

Review 6.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

7.  Altered Competitive Fitness, Antimicrobial Susceptibility, and Cellular Morphology in a Triclosan-Induced Small-Colony Variant of Staphylococcus aureus.

Authors:  Sarah Forbes; Joe Latimer; Abdulrahman Bazaid; Andrew J McBain
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

8.  Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics.

Authors:  Tânia Curiao; Emmanuela Marchi; Carlo Viti; Marco R Oggioni; Fernando Baquero; José Luis Martinez; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

9.  Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteins.

Authors:  Takehiko Mima; Swati Joshi; Margarita Gomez-Escalada; Herbert P Schweizer
Journal:  J Bacteriol       Date:  2007-08-24       Impact factor: 3.490

Review 10.  Expanding the paradigms of plant pathogen life history and evolution of parasitic fitness beyond agricultural boundaries.

Authors:  Cindy E Morris; Marc Bardin; Linda L Kinkel; Benoit Moury; Philippe C Nicot; David C Sands
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.